(c) 2024 PillSync.com

eszopiclone tablet

1 INDICATIONS AND USAGE Eszopiclone Tablets are indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, Eszopiclone Tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). Eszopiclone Tablets are indicated for the treatment of insomnia. Eszopiclone Tablets have been shown to decrease sleep latency and improve sleep maintenance ( 1 )

roxane laboratories, inc.


9 years ago ROUND WHITE 54 396 eszopiclone tablet

ROUND WHITE 54 396

9 years ago ROUND WHITE 54 396 eszopiclone tablet

54 396 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Eszopiclone Tablets, USP are round, white, biconvex, film-coated tablets and are supplied as follows: The 1 mg tablets are debossed with product identification “54” over “746” on one side and plain on the other side. NDC 0054-0290-13 1 mg, bottle of 30 NDC 0054-0290-25 1 mg, bottle of 100 The 2 mg tablets are debossed with product identification “54” over “029” on one side and plain on the other side. NDC 0054-0291-25 2 mg, bottle of 100 The 3 mg tablets are debossed with product identification “54” over “396” on one side and plain on the other side. NDC 0054-0292-25 3 mg, bottle of 100 Storage Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]


More pills like ROUND 54 396












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site